Astellas/Cardiome Reports Positive Kynapid Phase III Study
Astellas awaits past-due decision from FDA on candidate that met primary endpoint in two Phase III trials.
Astellas awaits past-due decision from FDA on candidate that met primary endpoint in two Phase III trials.